Cardiovascular toxicities associated with chimeric antigen receptor T-cell therapy.

Saved in:
Bibliographic Details
Title: Cardiovascular toxicities associated with chimeric antigen receptor T-cell therapy.
Authors: Liu JH; Cancer Center, The First Hospital of Jilin University, Changchun, China.; Cancer Research Institute of Jilin University, The First Hospital of Jilin University, Changchun, China.; International Center of Future Science, Jilin University, Changchun, China., Liu KY; Cancer Research Institute of Jilin University, The First Hospital of Jilin University, Changchun, China., Zhao X; Cancer Research Institute of Jilin University, The First Hospital of Jilin University, Changchun, China., Zhou X; Cancer Center, The First Hospital of Jilin University, Changchun, China.; Cancer Research Institute of Jilin University, The First Hospital of Jilin University, Changchun, China.; International Center of Future Science, Jilin University, Changchun, China., Jiang Y; Department of Pharmacy, China-Japan Union Hospital of Jilin University, Changchun, China.; Department of Clinical Pharmacy, The First Hospital of Jilin University, Changchun, China.
Source: Frontiers in pharmacology [Front Pharmacol] 2025 May 08; Vol. 16, pp. 1578157. Date of Electronic Publication: 2025 May 08 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40406483
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cardiovascular toxicities associated with chimeric antigen receptor T-cell therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Liu+JH%22">Liu JH</searchLink>; Cancer Center, The First Hospital of Jilin University, Changchun, China.; Cancer Research Institute of Jilin University, The First Hospital of Jilin University, Changchun, China.; International Center of Future Science, Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Liu+KY%22">Liu KY</searchLink>; Cancer Research Institute of Jilin University, The First Hospital of Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Zhao+X%22">Zhao X</searchLink>; Cancer Research Institute of Jilin University, The First Hospital of Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Zhou+X%22">Zhou X</searchLink>; Cancer Center, The First Hospital of Jilin University, Changchun, China.; Cancer Research Institute of Jilin University, The First Hospital of Jilin University, Changchun, China.; International Center of Future Science, Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Jiang+Y%22">Jiang Y</searchLink>; Department of Pharmacy, China-Japan Union Hospital of Jilin University, Changchun, China.; Department of Clinical Pharmacy, The First Hospital of Jilin University, Changchun, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2025 May 08; Vol. 16, pp. 1578157. <i>Date of Electronic Publication: </i>2025 May 08 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40406483
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2025.1578157
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1578157
    Titles:
      – TitleFull: Cardiovascular toxicities associated with chimeric antigen receptor T-cell therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Liu JH
      – PersonEntity:
          Name:
            NameFull: Liu KY
      – PersonEntity:
          Name:
            NameFull: Zhao X
      – PersonEntity:
          Name:
            NameFull: Zhou X
      – PersonEntity:
          Name:
            NameFull: Jiang Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 05
              Text: 2025 May 08
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1